Abstract:Ferroptosis is a newly described form of regulated cell death, distinct from apoptosis, necroptosis and other forms of cell death. Ferroptosis is induced by disruption of glutathione synthesis or inhibition of glutathione peroxidase 4, exacerbated by iron, and prevented by radical scavengers such as ferrostatin-1, liproxstatin-1, and endogenous vitamin E. Ferroptosis terminates with mitochondrial dysfunction and toxic lipid peroxidation. Although conclusive identification of ferroptosis in vivo is challenging, several salient and very well established features of neurodegenerative diseases are consistent with ferroptosis, including lipid peroxidation, mitochondrial disruption and iron dysregulation. Accordingly, interest in the role of ferroptosis in neurodegeneration is escalating and specific evidence is rapidly emerging. One aspect that has thus far received little attention is the antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). This transcription factor regulates hundreds of genes, of which many are either directly or indirectly involved in modulating ferroptosis, including metabolism of glutathione, iron and lipids, and mitochondrial function. This potentially positions Nrf2 as a key deterministic component modulating the onset and outcomes of ferroptotic stress. The minimal direct evidence currently available is consistent with this and indicates that Nrf2 may be critical for protection against ferroptosis. In contrast, abundant evidence demonstrates that enhancing Nrf2 signaling is potently neuroprotective in models of neurodegeneration, although the exact mechanism by which this is achieved is unclear. Further studies are required to determine to extent to which the neuroprotective effects of Nrf2 activation involve the prevention of ferroptosis.

Nrf2 and Ferroptosis: Exploring Translational Avenues for Therapeutic Approaches to Neurological Diseases

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases

Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases

Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders

NRF2, a Superstar of Ferroptosis

The role of ferroptosis in neurodegenerative diseases

A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: new insights into emerging mechanisms and therapeutic targets

The role of non-coding RNAs in ferroptosis regulation

Toward Improved Human Health: Nrf2 Plays a Critical Role in Regulating Ferroptosis

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis Mediated by Lipid Reactive Oxygen Species: A Possible Causal Link of Neuroinflammation to Neurological Disorders

Research on Ferroptosis as a Therapeutic Target for the Treatment of Neurodegenerative Diseases

Ferroptosis-Regulated Cell Death As a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects

Iron Homeostasis and Neurodegeneration in the Aging Brain: Insight into Ferroptosis Pathways

Deeper insight into ferroptosis: association with Alzheimer's, Parkinson's disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis

Targeting NRF2 to Suppress Ferroptosis in Brain Injury.